Open an account

Schwab Fundamental U.S. Small Company ETF

FNDA · ETF

$35.67−$0.17 (−0.47%)TodayMarket closed ·
Prev close $35.84

About FNDA

FNDA was created on 2013-08-15 by Schwab. The fund's investment portfolio concentrates primarily on small cap equity. The ETF currently has 8776.9m in AUM and 912 holdings. FNDA tracks a fundamentally selected and weighted index of small US firms based on adjusted sales, retained operation cash flow, and dividends plus buybacks.

Issuer
Schwab
Tracks
RAFI Fundamental High Liquidity US Small Index - Benchmark TR Gross
Expense ratio
0.25%
Assets under management
$8.81B
Inception
Aug 15, 2013
Asset class
Equity
Website
schwabassetmanagement.com

FNDA key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
2.48M
Volume
1.69M
Open price
$35.60
High today
$35.77
Low today
$35.42
52 Week high
$38.59
52 Week low
$29.31

Schwab Fundamental U.S. Small Company ETF (FNDA) at a glance

Schwab Fundamental U.S. Small Company ETF (FNDA) last traded at $35.67, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $35.42 and $35.77. The current price is 0.7% above the day's low and 0.3% below its high.

Volume so far is 1.69M shares, below the average of 2.48M shares a day.

Over the past year Schwab Fundamental U.S. Small Company ETF has ranged from $29.31 to $38.59, and now sits 69% of the way up that range.

FNDA news

  • Anusuya Lahiri

    What Is Going On With Super Micro Stock On Tuesday?

  • Akanksha Bakshi

    What's Going On With Super Micro Computer Stock Wednesday?

  • Anusuya Lahiri

    What Is Going On With Super Micro Stock On Tuesday?

  • Kaustubh Bagalkote

    What's Going On With Super Micro Stock Friday?

  • Akanksha Bakshi

    What's Going On With Super Micro Stock Thursday?

  • Lekha Gupta

    Billionaire Investor Boosts Rocket Companies Stake By 138% Despite Housing Market Pressures

  • Akanksha Bakshi

    Super Micro Stock Hits 52-Week Low - Here's Why

  • Vandana Singh

    Emergent BioSolutions Wins FDA Approval For New Narcan Multipacks To Expand Overdose Access

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.